Determination of Anlotinib, a Tyrosine Kinase Inhibitor, in Rat Plasma by UHPLC-MS/MS and Its Application to a Pharmacokinetic Study

Figure 1

Product ion mass spectra of anlotinib ([M+H]⁺ m/z 408.2 ⟶ 339.1) and imatinib ([M+H]⁺ m/z 494.3 ⟶ 394.1) in the positive ionization mode.

(a)

(b)